Nitric oxide and virus infection

Nitric oxide (NO) has complex and diverse functions in physiological and pathophysiological phenomena. The mechanisms of many events induced by NO are now well defined, so that a fundamental understanding of NO biology is almost established. Accumulated evidence suggests that NO and oxygen radicals such as superoxide are key molecules in the pathogenesis of various infectious diseases. NO biosynthesis, particularly through expression of an inducible NO synthase (iNOS), occurs in a variety of microbial infections. Although antimicrobial activity of NO is appreciated for bacteria and protozoa, NO has opposing effects in virus infections such as influenza virus pneumonia and certain other neurotropic virus infections. iNOS produces an excessive amount of NO for long periods, which allows generation of a highly reactive nitrogen oxide species, peroxynitrite, via a radical coupling reaction of NO with superoxide. Thus, peroxynitrite causes oxidative tissue injury through potent oxidation and nitration reactions of various biomolecules. NO also appears to affect a host's immune response, with immunopathological consequences. For example, overproduction of NO in virus infections in mice is reported to suppress type 1 helper T‐cell‐dependent immune responses, leading to type 2 helper T‐cell‐biased immunological host responses. Thus, NO may be a host response modulator rather than a simple antiviral agent. The unique biological properties of NO are further illustrated by our recent data suggesting that viral mutation and evolution may be accelerated by NO‐induced oxidative stress. Here, we discuss these multiple roles of NO in pathogenesis of virus infections as related to both non‐specific inflammatory responses and immunological host reactions modulated by NO during infections in vivo.

[1]  H. Maeda,et al.  Protective effect of S-nitrosylated alpha(1)-protease inhibitor on hepatic ischemia-reperfusion injury. , 2000, The Journal of pharmacology and experimental therapeutics.

[2]  T. Akaike,et al.  Tyrosine Nitration by Peroxynitrite Formed from Nitric Oxide and Superoxide Generated by Xanthine Oxidase* , 2000, The Journal of Biological Chemistry.

[3]  J. Beckman,et al.  Superoxide Reacts with Nitric Oxide to Nitrate Tyrosine at Physiological pH via Peroxynitrite* , 2000, The Journal of Biological Chemistry.

[4]  Gregory F. Wu,et al.  Coronavirus-Induced Demyelination Occurs in the Absence of Inducible Nitric Oxide Synthase , 2000, Journal of Virology.

[5]  H. Maeda,et al.  Helicobacter pylori Urease Suppresses Bactericidal Activity of Peroxynitrite via Carbon Dioxide Production , 2000, Infection and Immunity.

[6]  G. Dougan,et al.  Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. II. Effects on Microbial Proliferation and Host Survival in Vivo , 2000, The Journal of experimental medicine.

[7]  F. Fang,et al.  Antimicrobial Actions of the Nadph Phagocyte Oxidase and Inducible Nitric Oxide Synthase in Experimental Salmonellosis. I. Effects on Microbial Killing by Activated Peritoneal Macrophages in Vitro , 2000, The Journal of experimental medicine.

[8]  H. Maeda,et al.  Viral mutation accelerated by nitric oxide production during infection in vivo. , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  H. Ischiropoulos,et al.  Cooperation between Reactive Oxygen and Nitrogen Intermediates in Killing of Rhodococcus equi by Activated Macrophages , 2000, Infection and Immunity.

[10]  C. Nathan,et al.  Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. , 2000, Current opinion in microbiology.

[11]  T. Akaike Mechanisms of biological S-nitrosation and its measurement , 2000, Free radical research.

[12]  R. Zinkernagel,et al.  IL-4 and IL-10 Antagonize IL-12-Mediated Protection Against Acute Vaccinia Virus Infection with a Limited Role of IFN-γ and Nitric Oxide Synthetase 21 , 2000, The Journal of Immunology.

[13]  H. Maeda,et al.  Pathophysiological Effects of High-Output Production of Nitric Oxide , 2000 .

[14]  J S Beckman,et al.  Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. , 1999, Science.

[15]  A. Álvarez,et al.  Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  R. Hruban,et al.  Inducible nitric oxide synthase protection against coxsackievirus pancreatitis. , 1999, Journal of immunology.

[17]  A. Thomsen,et al.  Inducible nitric-oxide synthase plays a minimal role in lymphocytic choriomeningitis virus-induced, T cell-mediated protective immunity and immunopathology. , 1999, The Journal of general virology.

[18]  P. McMinn,et al.  The Severity of Murray Valley Encephalitis in Mice Is Linked to Neutrophil Infiltration and Inducible Nitric Oxide Synthase Activity in the Central Nervous System , 1999, Journal of Virology.

[19]  M. Hollenberg,et al.  Prevention of Encephalomyocarditis Virus-Induced Diabetes in Mice by Inhibition of the Tyrosine Kinase Signalling Pathway and Subsequent Suppression of Nitric Oxide Production in Macrophages , 1999, Journal of Virology.

[20]  A. Matsumori,et al.  Treatment of experimental viral myocarditis with interleukin-10. , 1999, Circulation.

[21]  F. Belardelli,et al.  Inhibitory Activity of Constitutive Nitric Oxide on the Expression of Alpha/Beta Interferon Genes in Murine Peritoneal Macrophages , 1999, Journal of Virology.

[22]  G. Barbarini,et al.  Intensity of myocardial expression of inducible nitric oxide synthase influences the clinical course of human immunodeficiency virus-associated cardiomyopathy. Gruppo Italiano per lo Studio Cardiologico dei pazienti affetti da AIDS (GISCA). , 1999, Circulation.

[23]  T. Kemper,et al.  Human immunodeficiency virus infection, inducible nitric oxide synthase expression, and microglial activation: Pathogenetic relationship to the acquired immunodeficiency syndrome dementia complex , 1999, Annals of neurology.

[24]  H. Tsutsumi,et al.  Respiratory syncytial virus infection of human respiratory epithelial cells enhances inducible nitric oxide synthase gene expression , 1999, Journal of leukocyte biology.

[25]  T. Sairenji,et al.  Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. , 1999, Virology.

[26]  M. Zeng,et al.  Fas-induced caspase denitrosylation. , 1999, Science.

[27]  H. Maeda,et al.  Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. , 1999, Virology.

[28]  K. Clouse,et al.  Human immunodeficiency virus-1-infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: astrocytic NO as a possible mediator of neural damage in acquired immunodeficiency syndrome. , 1999, Blood.

[29]  C. Lowenstein,et al.  An Antiviral Mechanism of Nitric Oxide , 1999, Immunity.

[30]  T. Dawson,et al.  Mechanisms and Structural Determinants of HIV-1 Coat Protein, gp41-Induced Neurotoxicity , 1999, The Journal of Neuroscience.

[31]  D. Stuehr Mammalian nitric oxide synthases. , 1999, Biochimica et biophysica acta.

[32]  M. Dinauer,et al.  Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. , 1999, Immunity.

[33]  H. Kolb,et al.  Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? , 1998, Immunology today.

[34]  G. Karupiah,et al.  Rapid Interferon γ–dependent Clearance of Influenza A Virus and Protection from Consolidating Pneumonitis in Nitric Oxide Synthase 2–deficient Mice , 1998, The Journal of experimental medicine.

[35]  M. Beck,et al.  Glutathione peroxidase protects mice from viral‐induced myocarditis , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  G. Karupiah,et al.  Identification of Nitric Oxide Synthase 2 as an Innate Resistance Locus against Ectromelia Virus Infection , 1998, Journal of Virology.

[37]  G. Wogan,et al.  Mutagenesis associated with nitric oxide production in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[38]  F. Liew,et al.  Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. , 1998, The Journal of general virology.

[39]  E. Lara-Pezzi,et al.  Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation. , 1998, The Journal of clinical investigation.

[40]  C. Lowenstein,et al.  The role of inducible nitric oxide synthase in the host response to Coxsackievirus myocarditis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Akaike,et al.  Free Radicals in Viral Pathogenesis: Molecular Mechanisms Involving Superoxide and NO , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[42]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[43]  H. Esumi,et al.  Nitric oxide inhibits CPP32-like activity under redox regulation. , 1997, Biochemical and Biophysical Research Communications - BBRC.

[44]  H. Maeda,et al.  Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice , 1997, Infection and immunity.

[45]  H. Maeda,et al.  Activation of human neutrophil procollagenase by nitrogen dioxide and peroxynitrite: a novel mechanism for procollagenase activation involving nitric oxide. , 1997, Archives of biochemistry and biophysics.

[46]  A. Sher,et al.  Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. , 1997, Journal of immunology.

[47]  J. Mudgett,et al.  Identification of nitric oxide synthase as a protective locus against tuberculosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  L. Kobzik,et al.  Suppression of Herpes Simplex Virus Type 1 (HSV-1)–induced Pneumonia in Mice by Inhibition of Inducible Nitric Oxide Synthase (iNOS, NOS2) , 1997, The Journal of experimental medicine.

[49]  X. Mo,et al.  The cytotoxic T-lymphocyte response to Sendai virus is unimpaired in the absence of gamma interferon , 1997, Journal of virology.

[50]  X. Mo,et al.  Modification of the Sendai virus-specific antibody and CD8+ T-cell responses in mice homozygous for disruption of the interleukin-4 gene , 1997, Journal of virology.

[51]  M. Takiguchi,et al.  Coinduction of Nitric-oxide Synthase and Arginase I in Cultured Rat Peritoneal Macrophages and Rat Tissues in Vivo by Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.

[52]  H. Lander An essential role for free radicals and derived species in signal transduction , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[54]  M. Takiguchi,et al.  Molecular cloning of cDNA for nonhepatic mitochondrial arginase (arginase II) and comparison of its induction with nitric oxide synthase in a murine macrophage‐like cell line , 1996, FEBS letters.

[55]  B. Freeman,et al.  Nitric oxide regulation of tissue free radical injury. , 1996, Chemical research in toxicology.

[56]  M. Eibl,et al.  Nitric oxide and viral infection: NO antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. , 1996, Virology.

[57]  K. Hirata,et al.  Expression of nitric oxide synthase in a murine model of viral myocarditis induced by coxsackievirus B3. , 1996, Biochemical and biophysical research communications.

[58]  H. Maeda,et al.  Pathogenesis of influenza virus-induced pneumonia: involvement of both nitric oxide and oxygen radicals. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[59]  G. Wogan,et al.  Peroxynitrite-induced mutation spectra of pSP189 following replication in bacteria and in human cells. , 1996, Mutation research.

[60]  H. Masumoto,et al.  The reaction of ebselen with peroxynitrite. , 1996, Chemical research in toxicology.

[61]  Rolf M. Zinkernagel,et al.  Immunology Taught by Viruses , 1996, Science.

[62]  M. Eibl,et al.  SHORT COMMUNICATION Nitric Oxide and Viral Infection: No Antiviral Activity against a Flavivirus in Vitro, and Evidence for Contribution to Pathogenesis in Experimental Infection in Vivo , 1996 .

[63]  H. Ohshima,et al.  Formation of 8‐nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination , 1995, FEBS letters.

[64]  S. James Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.

[65]  H. Ohshima,et al.  Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. , 1995, Carcinogenesis.

[66]  F. Fang,et al.  Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  I. Charles,et al.  Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.

[68]  M. Beck,et al.  Rapid genomic evolution of a non-virulent Coxsackievirus B3 in selenium-deficient mice results in selection of identical virulent isolates , 1995, Nature Medicine.

[69]  A. Nomoto,et al.  Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor , 1995, The Journal of experimental medicine.

[70]  S. Lipton,et al.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV- associated neurological disease , 1995, The Journal of experimental medicine.

[71]  M. Modolell,et al.  Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. , 1995, Biochemical and biophysical research communications.

[72]  M. Schaefer,et al.  Effect of neurotropic virus infection on neuronal and inducible nitric oxide synthase activity in rat brain. , 1995, Journal of neurovirology.

[73]  J. Stamler,et al.  Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation , 1994, Cell.

[74]  M. Graham,et al.  Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection , 1994, The Journal of experimental medicine.

[75]  A. Taylor-Robinson,et al.  Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.

[76]  Y. Vodovotz,et al.  Mechanism of suppression of nitric oxide synthase expression by interleukin‐4 in primary mouse macrophages , 1994, Journal of leukocyte biology.

[77]  J. Stamler,et al.  Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[78]  M. Graham,et al.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene , 1993, The Journal of experimental medicine.

[79]  Z. Fu,et al.  Severity of neurological signs and degree of inflammatory lesions in the brains of rats with Borna disease correlate with the induction of nitric oxide synthase , 1993, Journal of virology.

[80]  G. Karupiah,et al.  Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. , 1993, Science.

[81]  H. Maeda,et al.  Pronounced enhancement of .NO-dependent antimicrobial action by an .NO-oxidizing agent, imidazolineoxyl N-oxide , 1993, Infection and immunity.

[82]  Y. Vodovotz,et al.  Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.

[83]  K. Croen,et al.  Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. , 1993, The Journal of clinical investigation.

[84]  H. Maeda,et al.  Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis , 1993, Infection and immunity.

[85]  A. Ramsay,et al.  A case for cytokines as effector molecules in the resolution of virus infection. , 1993, Immunology today.

[86]  L. Rorke,et al.  In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[87]  P. López-Jaramillo,et al.  The L-arginine: nitric oxide pathway. , 1993, Current opinion in nephrology and hypertension.

[88]  J. Stamler,et al.  Biochemistry of nitric oxide and its redox-activated forms. , 1992, Science.

[89]  S. Moncada,et al.  Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. , 1992, Biochemical and biophysical research communications.

[90]  T. Akaike,et al.  Oxygen Free Radicals as Pathogenic Molecules in Viral Diseases , 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[91]  R. Jaenisch,et al.  Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells , 1991, The Journal of experimental medicine.

[92]  C. Nathan,et al.  Role of nitric oxide synthesis in macrophage antimicrobial activity. , 1991, Current opinion in immunology.

[93]  H. Maeda,et al.  Dependence on O2- generation by xanthine oxidase of pathogenesis of influenza virus infection in mice. , 1990, The Journal of clinical investigation.

[94]  B. Freeman,et al.  Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[95]  S. Jonjić,et al.  Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes , 1989, The Journal of experimental medicine.

[96]  J. Perfect,et al.  Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages. , 1988, The Journal of clinical investigation.

[97]  S. Weitzman,et al.  Mutation caused by human phagocytes. , 1981, Science.

[98]  J. A. Badwey,et al.  Active oxygen species and the functions of phagocytic leukocytes. , 1980, Annual review of biochemistry.

[99]  J. Bennink,et al.  Different rules govern help for cytotoxic T cells and B cells , 1978, Nature.